Identification of human tumor antigens and its implications for diagnosis and treatment of cancer. - Wikidata - awgldk - TriplyDB

Identification of human tumor antigens and its implications for diagnosis and treatment of cancer.

Identification of human tumor antigens and its implications for diagnosis and treatment of cancer.

http://www.wikidata.org/entity/Q35927479

about

Role of α-gal epitope/anti-Gal antibody reaction in immunotherapy and its clinical application in pancreatic cancer Frequent immune response to a melanocyte specific protein KU-MEL-1 in patients with Vogt-Koyanagi-Harada disease Preferential expression and frequent IgG responses of a tumor antigen, SOX5, in glioma patients.Immunosuppression through constitutively activated NF-κB signalling in human ovarian cancer and its reversal by an NF-κB inhibitor.RAB8A a new biomarker for endometrial cancer?Strategies for the identification of T cell-recognized tumor antigens in hematological malignancies for improved graft-versus-tumor responses after allogeneic blood and marrow transplantation Tumor immunology, immunomics and targeted immunotherapy for central nervous system malignancies.Reverse immunology approach for the identification of CD8 T-cell-defined antigens: advantages and hurdles.SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade.Identification of T-cell epitopes for cancer immunotherapy.Expression of cancer/testis antigens is correlated with improved survival in glioblastoma.The cancer antigenome.T cell-based targeted immunotherapies for patients with multiple myeloma.Advances in personalized cancer immunotherapy.Antigen Discovery and Therapeutic Targeting in Hematologic Malignancies.The "Achilles Heel" of Cancer and Its Implications for the Development of Novel Immunotherapeutic Strategies.RNA interference (RNAi) of Ufd1 protein can sensitize a hydroxycamptothecin-resistant colon cancer cell line SW1116/HCPT to hydroxycamptothecin.The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells.Anti-tumor effect of the anti-KL-6/MUC1 monoclonal antibody through exposure of surface molecules by MUC1 capping.Improvement of cancer immunotherapy by combining molecular targeted therapy.Immuno-cell therapy with antecedent surgery has superior actuarial survival to immuno-cell therapy without antecedent surgery for advanced cancers.Cancer-induced immunosuppressive cascades and their reversal by molecular-targeted therapy.Phase I clinical trial of vaccination with LY6K-derived peptide in patients with advanced gastric cancer.

P2860

Q27024368-D156A0F4-2B95-4CE7-AD73-3BBBD645CAD1 Q33234061-2AA62879-ED03-4B7F-B27E-50887C8DE58F Q33269548-EFD1F6B9-8EC9-4381-A0D2-DDEB414366E2 Q33750160-5E98A634-028D-450A-A4DD-C7EEDA5E2B6A Q34897971-20F2FEA6-7501-481B-BC66-266A58B5BFB9 Q35588845-98CC55E8-D7BF-4895-A37D-13558B564C23 Q36273691-A35BF9B1-9318-497D-8883-407597912A03 Q36471831-BE937C1D-27B8-4539-94E4-B6BD717BD642 Q36491182-EAD961DB-D60F-4D05-B1C4-60408113868A Q36870592-1F932666-2B3F-4714-8AF4-4D0A25F58364 Q37038420-54A30B46-88F0-44AB-85BA-A98047706FEA Q38069075-37A60FED-058D-4991-AE6F-1274C4C47FFF Q38246639-D9A530AF-F951-486D-B65C-B6D719DC6DC3 Q38783946-B0AB483E-7C70-4BF1-BBC7-119CE728E3D1 Q39243052-40ACA02C-4E2A-49AD-AFD0-77EE96391B79 Q39384440-D7DB6241-858C-4CC9-B6F9-2479389A7486 Q39576447-0F99EFB0-FD3A-4E53-B0BF-5FEFA8A4C443 Q40262620-C268050B-FFE6-438B-9374-BFF26355AF07 Q40289314-44FC1A8F-DCBA-4DD3-9BE5-ADF7ADAAEDAA Q41075854-788E3B19-7113-44EA-86CC-2D76A5912902 Q45060813-992FB1C1-0CA9-456D-8B9E-EE193A1737A6 Q50901745-82BDFF87-95D3-443B-A3A0-F957DCE59766 Q51047134-3EB885BB-4167-4862-86C4-B2D85FBE5BE1

P2860

Identification of human tumor antigens and its implications for diagnosis and treatment of cancer.

http://www.wikidata.org/entity/Q35927479

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Identification of human tumor ...... nosis and treatment of cancer.

@ast

Identification of human tumor ...... nosis and treatment of cancer.

@en

type

label

Identification of human tumor ...... nosis and treatment of cancer.

@ast

Identification of human tumor ...... nosis and treatment of cancer.

@en

prefLabel

Identification of human tumor ...... nosis and treatment of cancer.

@ast

Identification of human tumor ...... nosis and treatment of cancer.

@en

P1433

Q35927479-403A09C2-F3C0-486D-BFFD-27A5FFB307D0

P1476

Q35927479-1E8647BF-38B8-420E-9110-CF7C6FC3EC51

P2093

Q35927479-0C61631B-2E36-4E0A-AE94-28A3CE17950F

Q35927479-1208DA1D-F14A-45BA-8B62-DAD66DC45795

Q35927479-46BEE909-3685-4BB0-9258-3C54BF35852C

Q35927479-4A8D875D-E67E-4D4A-868E-423FA3B0C5E3

Q35927479-8B43BA99-118B-48BA-BC28-31D8AE96717B

Q35927479-B029CAA8-D640-4B25-B2F2-5F0C0201FCB8

Q35927479-F77570CE-ADC2-4D56-BD74-3C8FC9B447D2

P2860

Q35927479-026BCEA2-DDBF-432B-B8AE-A0FCCA7A74F5

Q35927479-0C48980F-2A05-4E8C-A9AF-65B6043D647A

Q35927479-0C727E82-1907-455B-BC8F-96DE47656C8E

Q35927479-0C740ABD-43E2-41D0-83D5-013EDD719539

Q35927479-0CA27EF9-FEA1-4697-B2BE-EB7D2236EEDF

Q35927479-1E75B1CF-C131-4656-9A83-340BED3F68D1

Q35927479-24E1A6A7-92BF-464F-92E5-FB016D48F664

Q35927479-3086DA94-FEE0-4D27-8633-AA55B4CBA8C2

Q35927479-39F6F0DD-7AED-4F52-BDF0-1C8D34E0B7FB

Q35927479-4087D929-1274-4D20-96F8-C6D4BB954809

P304

Q35927479-6519EAFE-88B7-40FD-939B-BAD2ED9A81F7

P31

Q35927479-6D71FC00-A5A6-4558-B0D1-716B95B563CE

P356

Q35927479-B91FDD6C-9C58-4A4F-A6CD-C3A113BAA1C6

P433

Q35927479-74F73FE7-07F1-446F-8920-8FAD21CAB5C8

P478

Q35927479-E1D33547-8989-450F-AA5E-722B78886617

P577

Q35927479-06C8B36B-97DA-4D30-A28B-C29DA49A1249

P5875

Q35927479-0444EE19-1493-4A48-98CF-10233163A038

P698

Q35927479-7749A38F-9C1E-4C8E-9C68-F2BD4D2BFCCC

P356

J.1349-7006.2004.TB02182.X

P1433

P1476

Identification of human tumor ...... nosis and treatment of cancer.

@en

P2093

Hidetoshi Sumimoto

http://www.w3.org/2001/XMLSchema#string

Makoto Tsukamoto

http://www.w3.org/2001/XMLSchema#string

Masahiro Toda

http://www.w3.org/2001/XMLSchema#string

Tomonobu Fujita

http://www.w3.org/2001/XMLSchema#string

Toshiharu Sakurai

http://www.w3.org/2001/XMLSchema#string

Yuriko Matsuzaki

http://www.w3.org/2001/XMLSchema#string

Yutaka Kawakami

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

Stabilization of beta-catenin by genetic defects in melanoma cell lines

Biochemical identification of a mutated human melanoma antigen recognized by CD4(+) T cells.

Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity.

Identification of a human glioma antigen, SOX6, recognized by patients' sera.

Isolation of a new melanoma antigen, MART-2, containing a mutated epitope recognized by autologous tumor-infiltrating T lymphocytes.

In vivo activation of melanoma-specific CD8(+) T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus-specific T cells.

Identification of bladder cancer antigens recognized by IgG antibodies of a patient with metastatic bladder cancer.

P304

784-791

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1349-7006.2004.TB02182.X

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

95

http://www.w3.org/2001/XMLSchema#string

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8213477

http://www.w3.org/2001/XMLSchema#string

P698

15504244

http://www.w3.org/2001/XMLSchema#string